Abiopharma

Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives

V2X Names Mike Uster Chief Information Officer to Advance Enterprise Technology Strategy

Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

Lincoln Electric Schedules Webcast for First Quarter 2026 Results

MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy

General Announcement: Drilling programme in Yumna Field, Oman now expected to start in May 2026

General Announcement: Share Transaction of Person Discharging Managerial Responsibilities

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001193125-26-139267 <b>Size:</b> 239 KB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001140361-26-012911 <b>Size:</b> 547 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001918704-26-009100 <b>Size:</b> 972 KB

NAMIB MINERALS (NAMMW) Files Form 6-K

New Form 424B2 - UBS AG <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001839882-26-018808 <b>Size:</b> 493 KB

(100% Positive) ACUITY INC. (DE) (AYI) Reports Q2 2026 Financial Results

Namib Minerals Provides Business Update and Reports Full Year 2025 Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001918704-26-009098 <b>Size:</b> 640 KB